Roswell Park Cancer Institute - 06 FE Study — Buffalo, New York

Roswell Park Cancer Institute - 06 FE Study is a clinical research site located in Buffalo, New York, United States 14263.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Roswell Park Cancer Institute - 06 FE Study has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes.

Sponsors: Taiho Oncology, Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Roswell Park Cancer Institute - 06 FE Study?

Roswell Park Cancer Institute - 06 FE Study has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Roswell Park Cancer Institute - 06 FE Study conducted?

Roswell Park Cancer Institute - 06 FE Study has 1 clinical trials on record, with 1 currently active. Their work covers Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes.

Is Roswell Park Cancer Institute - 06 FE Study accredited by Crixeo Health?

Roswell Park Cancer Institute - 06 FE Study has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Roswell Park Cancer Institute - 06 FE Study?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.